Recombinant Complement 1 Inhibitor (C1INH)
Cat#:TP03905应用:Positive Control; Immunogen; SDS-PAGE; WB
Product Name: | SERPING1 Rabbit pAb |
Cat No.: | DPA01812 |
Clonality: | Polyclonal |
Species Reactivity: | Human |
Tested Applications: | WB,IP |
Recommended Dilution: | WB: 1:1000 IP: 1:20 |
Size: | 30ul 50ul 100uL |
Format: | Liquid |
Source: | Rabbit |
Purification Method: | Affinity Purification |
Isotype: | IgG |
Conjugate: | Un-conjugated |
Storage: | Store at -20°C. Supplied in 50nM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide a |
Immunogen: | A synthetic peptide of human SERPING1 |
Calculated Molecular Weight: | 55 kDa |
Observed Molecular Weight: | 100 kDa |
GenBank Accession Number: | P05155 |
Gene ID (NCBI): | 710 |
Synonyms: | C1IN; C1NH; HAE1; HAE2; C1INH |
Background: | This gene encodes a highly glycosylated plasma protein involved in the regulation of the complement cascade. Its encoded protein, C1 inhibitor, inhibits activated C1r and C1s of the first complement component and thus regulates complement activation. It is synthesized in the liver, and its deficiency is associated with hereditary angioneurotic oedema (HANE). Alternative splicing results in multiple transcript variants encoding the same isoform. [provided by RefSeq, May 2020] |
Category: | Primary Ab |